Purchase Order 75N93023P01028

Award Date 8/3/23
Potential Completion Date 9/29/23
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Madison, WI 53711, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
6
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $14,168.70 firm fixed-price purchase order to Molecular Devices LLC for a SPECTRAMAX MICROPLATE READER (AMBIS #2183390). Performance will take place in San Jose, California over a period of approximately four months concluding in late December 2023. As part of its mission to conduct and support medical research, the funding agency likely requires the...
The U.S. Department of Health and Human Services (HHS) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $5,805.80 firm-fixed-price purchase order to Promega Corporation, a global life sciences company, for a luminometer system. The award did not utilize any set-aside designations. Promega has provided a range of specialized laboratory equipment, reagents, and services to support biomedical research and testing programs across various federal agencies, including the NIH,...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order to Molecular Devices LLC, a subsidiary of Danaher Corporation, for the delivery of one Flexstation3 Microplate Reader with SoftMax Pro Software. The $141,945.00 award was made on August 24, 2021, with a completion date of September 30, 2021. The procurement was conducted under simplified acquisition...
This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Promega Corporation, a global life sciences company based in Madison, Wisconsin. The contract, valued at $79,736.40, is for the delivery of a LUCIFERASE 1000 ASSAY (AMBIS #1676428) product from Promega. This award does not utilize any set-aside designation. Promega is a major supplier of specialized laboratory equipment,...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $107,862 firm fixed price purchase order to Agilent Technologies Inc. to provide a Biotek Synergy Neo2 multi-mode plate reader and associated accessories. The equipment will support the Vaccine Research Center's studies of viral pathogenesis including coronavirus, enabling diagnostic identification and vaccine/therapeutic development. Deliverables include the...
This $6,249.10 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services, to Promega Corporation for the BRIGHT-GLO Luciferase Assay System. The contract did not utilize a set-aside designation. Promega is a global life sciences company that develops, manufactures, and markets integrated systems and reagents for biological research, molecular diagnostics, and forensic...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Promega Corporation, a global life sciences company based in Madison, Wisconsin. The award, valued at $19,874.40, is for the procurement of 26 units of the LUCIFERASE 1000 REAGENT, Catalog # E4550, at $382.20 per unit. This is a Firm Fixed Price Blanket Purchase Agreement (BPA) call order with a completion date of March 8, 2012....
This is a $13,289.40 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Promega Corporation for the purchase of luciferase reagents. The contract has an ultimate completion date of April 11, 2014 and does not utilize any set-aside designations. Promega Corporation is a global life sciences company that provides a wide range of products and services to support biomedical...
This is a $18,960.60 purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency within the Department of Health and Human Services, to Promega Corporation, a large business that manufactures life sciences products for government customers. The contract, which does not utilize a set-aside designation, is for the supply of a GloMax luminometer and related equipment for the agency's ARRA (American Recovery and Reinvestment Act) funded research activities. Promega...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to BMG Labtech, Inc., a leading global manufacturer and supplier of specialized laboratory equipment and instrumentation. The $9,999.36 firm fixed-price purchase order contract is for the delivery of BMG Labtech's microplate readers, spectrometers, and related accessories to support critical biomedical research across various federal...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $28,077.90 firm fixed price purchase order to Promega Corporation for a GloMax(R) Explorer Fully Loaded Model (AMBIS #2180066). The products and services to be delivered under this contract include the GloMax(R) Explorer multimode microplate reader specified in Solicitation AMBIS 2180066, along with shipping and handling. The microplate reader will provide luminescence, fluorescence, UV-visible absorbance, BRET, FRET, and two-color filtered luminescence detection capabilities for use in the Neuroimmunological Diseases Section's experiments. Place of performance will be Promega Corporation's facilities in Madison, Wisconsin. The period of performance is August 3, 2023 through September 29, 2023.

Generated 12/22/23, 9:27 PM